- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sanofi Consumer Healthcare India Limited and Clayton, Dubilier & Rice, LLC (CD&R Group) have entered exclusive negotiations for CD&R to acquire a controlling stake in Opella Healthcare SAS, subject to Sanofi finalizing the acquisition. The agreement was signed on 18 February 2025, with the CD&R Group to subsequently make a mandatory open offer. Upon completion of the acquisition, CD&R Group will acquire indirect control over Sanofi's voting rights in the company, which currently holds 60.40% of the equity share capital through Opella Healthcare Participations B.V. This strategic move could strengthen CD&R's influence over Sanofi’s operations, marking a significant shift in management control. Closing is expected by 30 April 2025, depending on regulatory approvals. Investors should monitor this development closely, as it may have considerable implications for governance and strategic direction moving forward.
All announcements from Sanofi Consumer Healthcare India Limited